体外診断薬(IVD)の米国市場

【英語タイトル】U.S. IVD Market by Product Type (Reagents, Instruments, and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and by End Users (Standalone Laboratory, Hospitals, Academic and Medical Schools, Point of Care Testing, and Others) - Opportunity Analysis and Industry Forecast, 2017-2023

Allied Market Researchが出版した調査資料(AMR8040232)・商品コード:AMR8040232
・発行会社(調査会社):Allied Market Research
・発行日:2017年9月
・ページ数:140
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:米国
・産業分野:Medical Devices & Supplies
◆販売価格オプション(消費税別)
Single UserUSD2,850 ⇒換算¥322,050見積依頼/購入/質問フォーム
5 UserUSD3,551 ⇒換算¥401,263見積依頼/購入/質問フォーム
Enterprise UserUSD3,979 ⇒換算¥449,627見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

In vitro diagnostics (IVD) is the diagnostic solution used by patients for detection of various diseases such as infections, cancer, cardiovascular immunological, nephrological, and gastroenterological diseases in an in vitro environment. The continuous need for diagnosis and treatment of different diseases has makes way for the need of numerous technological advancements in the IVD market. These advancements continue in future as well to identify new diseases, improve living standards, and provide healthcare access to the patients. IVD testing is performed by using reagents, analytical instruments, and accessory products.
Increase in infectious and chronic diseases and rise in geriatric population drive the market. In addition, demand for personalized medicines and technological advancements to improve efficacy of IVD, rise in disposable income, and high healthcare expenditure are expected to fuel the market growth. Furthermore, increase in awareness of preventive diagnosis & treatment among the population is anticipated to increase the market growth during the forecast period. However, stringent government rules and regulations are expected to hinder the growth of this market. Ongoing R&D is anticipated to present new opportunities for the market. The U.S. IVD market is accounted for $15,746 million in 2016, and is estimated to reach at $20,707 million by 2023, growing at a CAGR of 3.9% from 2017 to 2023.

The market is segmented on the basis of product type, techniques, application, and end user. By product type, the market is categorized into reagents, instruments, and software & services. On the basis of techniques, it is divided into immunodiagnostics, blood testing, molecular diagnostics, tissue diagnostics, clinical chemistry, and other IVD techniques. Application segment covered in the study includes infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and other indications. Based on end user, it is classified into hospitals, academic and medical schools, point of care testing, and others.

KEY BENEFITS FOR SHAREHOLDERS

The study provides an in-depth analysis of the U.S. IVD market, with current trends and future estimations to elucidate the investment pockets.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
The report provides a quantitative analysis from 2016 to 2023, which enables stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of different segments facilitates to understand various products of the market.
Key players are profiled and their strategies are analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS

By Product Type

Reagents
Instruments
Software and Services
By Techniques

Immunodiagnostics
Enzyme-Linked Immunosorbent Assay (ELISA)
Chemiluminescence Immunoassays (CLIAS)
Fluorescence Immunoassays (FIAS)
Colorimetric Immunoassays (CIS)
Rapid Tests
Enzyme-Linked Immunospot Assays (ELISPOT)
Radioimmunoassay
Western Blot
Blood Testing
Molecular Diagnostics
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Hybridization
DNA Diagnostics
Microarrays
Others
Tissue Diagnostics
Clinical Chemistry
Basic Metabolic Panel
Liver Panel
Lipid Profile
Thyroid Function Panel
Renal Profile
Electrolyte Panel
Specialty Chemicals
Other IVD Techniques
By Application

Infectious Diseases
Cancer
Cardiac Diseases
Immune System Disorders
Nephrological Diseases
Gastrointestinal Diseases
Other Indications
By End Users

Standalone Laboratory
Hospitals
Academic and Medical Schools
Point of Care Testing
Others
List of players profiled in the report

Thermo Fisher Scientific Inc.
Alere Inc.
Biomerieux
Danaher Corporation
F. Hoffmann-La Roche AG
Becton Dickinson and Company
Bio-Rad Laboratories
Bayer AG
Sysmex Corporation
Johnson & Johnson

【レポートの目次】

CHAPTER 1 INTRODUCTION

1.1 REPORT DESCRIPTION
1.2 KEY BENEFITS
1.3 KEY MARKET SEGMENTS
1.4 RESEARCH METHODOLOGY

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1 MARKET DEFINITION AND SCOPE
3.2 KEY FINDINGS

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 PORTERS FIVE FORCES ANALYSIS

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Threat of substitute
3.3.5 Competitive rivalry

3.4 MARKET SHARE ANALYSIS, 2016
3.5 MARKET DYNAMICS

3.5.1 Drivers

3.5.1.1 Increasing incidence of chronic and infectious diseases
3.5.1.2 Technological advancements in IVD
3.5.1.3 Emergence of minimal invasive technologies
3.5.1.4 Increasing government expenditures on healthcare
3.5.1.5 Increase in popularity of personalized medicine approach

3.5.2 Restraint

3.5.2.1 Unclear reimbursement policies
3.5.2.2 Stringent regulatory policies

3.5.3 Opportunity

3.5.3.1 Potential opportunities for outsourcing
3.5.3.2 Convergence of new technologies

CHAPTER 4 IVD MARKET, BY PRODUCT TYPE

4.1 OVERVIEW

4.1.1 Market size and forecast

4.2 REAGENTS

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 INSTRUMENTS

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 SOFTWARE AND SERVICES

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

CHAPTER 5 IVD MARKET, BY TECHNIQUE

5.1 OVERVIEW

5.1.1 Market size and forecast

5.2 IMMUNODIAGNOSTICS

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 Enzyme-linked immunosorbent assay (ELISA)

5.2.4.1 Market size and forecast
5.2.4.2 Chemiluminescence immunoassay (CLIA)

5.2.4.2.1 Market size and forecast

5.2.4.3 Fluorescence immunoassay (FIA)

5.2.4.3.1 Market size and forecast

5.2.4.4 Colorimetric immunoassay (CI)

5.2.4.4.1 Market size and forecast

5.2.5 Rapid tests

5.2.5.1 Market size and forecast

5.2.6 Enzyme-linked immunospot (ELISPOT)

5.2.6.1 Market size and forecast

5.2.7 Radioimmunoassay (RIA)

5.2.7.1 Market size and forecast

5.2.8 Western blot

5.2.8.1 Market size and forecast

5.3 BLOOD TESTING

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast

5.4 MOLECULAR DIAGNOSTICS

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 Polymerize chain reaction (PCR)

5.4.4.1 Market size and forecast

5.4.5 Isothermal nucleic acid technology (INAAT)

5.4.5.1 Market size and forecast

5.4.6 Hybridization

5.4.6.1 Market size and forecast

5.4.7 DNA diagnostics

5.4.7.1 Market size and forecast

5.4.8 Microarray

5.4.8.1 Market size and forecast

5.4.9 Others

5.4.9.1 Market size and forecast

5.5 TISSUE DIAGNOSTICS

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast

5.6 CLINICAL CHEMISTRY

5.6.1 Key market trends
5.6.2 Key growth factors and opportunities
5.6.3 Market size and forecast
5.6.4 Basic metabolic panel

5.6.4.1 Market size and forecast

5.6.5 Liver panel

5.6.5.1 Market size and forecast

5.6.6 Renal profile

5.6.6.1 Market size and forecast

5.6.7 Lipid profile

5.6.7.1 Market size and forecast

5.6.8 Thyroid function panel

5.6.8.1 Market size and forecast

5.6.9 Electrolyte panel

5.6.9.1 Market size and forecast

5.6.10 Speciality chemicals

5.6.10.1 Market size and forecast

5.7 OTHER IVD TECHNIQUES

5.7.1 Key market trends
5.7.2 Key growth factors and opportunities
5.7.3 Market size and forecast

CHAPTER 6 IVD MARKET, BY APPLICATION

6.1 INFECTIOUS DISEASES

6.1.1 Key market trends
6.1.2 Key growth factors and opportunities
6.1.3 Market size and forecast

6.2 CANCER

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast

6.3 CARDIAC DISEASES

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast

6.4 IMMUNE SYSTEM DISORDERS

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast

6.5 NEPHROLOGICAL DISEASES

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast

6.6 GASTROINTESTINAL DISEASES

6.6.1 Key market trends
6.6.2 Key growth factors and opportunities
6.6.3 Market size and forecast

6.7 OTHERS INDICATIONS

6.7.1 Key market trends
6.7.2 Key growth factors and opportunities
6.7.3 Market size and forecast

CHAPTER 7 IVD MARKET BY END USERS

7.1 STANDALONE LABORATORIES

7.1.1 Market size and forecast

7.2 HOSPITALS

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast

7.3 ACADEMIC AND MEDICAL SCHOOLS

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast

7.4 POINT OF CARE TESTING

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast

7.5 OTHERS END-USER

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1 THERMO FISHER SCIENTIFIC INC.

8.1.1 Company overview
8.1.2 Business performance
8.1.3 Key strategies and development

8.2 ALERE INC.

8.2.1 Company overview
8.2.2 Business performance
8.2.3 Key strategies and developments

8.3 BIOMERIEUX

8.3.1 Company overview
8.3.2 Business performance
8.3.3 Key strategies and developments

8.4 DANAHER CORPORATION

8.4.1 Company overview
8.4.2 Business performance
8.4.3 Key strategies and development

8.5 F. HOFFMANN-LA ROCHE AG

8.5.1 Company overview
8.5.2 Business performance
8.5.3 Key strategies and developments

8.6 BECTON DICKINSON AND COMPANY

8.6.1 Company overview
8.6.2 Business performance
8.6.3 Key strategies and development

8.7 BIO-RAD LABORATORIES

8.7.1 Company overview
8.7.2 Business performance
8.7.3 Key strategies and developments

8.8 BAYER AG

8.8.1 Company overview
8.8.2 Business performance
8.8.3 Key strategies and development

8.8 SYSMEX CORPORATION

8.8.1 Company overview
8.8.2 Business performance
8.8.3 Key strategies and developments

8.10 JOHNSON & JOHNSON

8.10.1 Company overview
8.10.2 Business performance
8.10.3 Key strategies and development

TABLE 1 INCIDENCE OF DISEASES
TABLE 2 U.S. IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 3 U.S. IVD REAGENTS MARKET, 2016-2023 ($MILLION)
TABLE 4 U.S. IVD INSTRUMENTS MARKET, 2016-2023 ($MILLION)
TABLE 5 U.S. IVD SOFTWARE & SERVICES MARKET, 2016-2023 ($MILLION)
TABLE 6 U.S. IVD MARKET BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 7 U.S. IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY TYPES, 2016-2023 ($MILLION)
TABLE 8 U.S. IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, 2016-2023 ($MILLION)
TABLE 9 U.S. IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET FOR ELISA, BY TYPES, 2016-2023 ($MILLION)
TABLE 10 U.S. IVD BLOOD TESTING TECHNIQUE MARKET, 2016-2023 ($MILLION)
TABLE 11 U.S. IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 12 U.S. IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, 2016-2023 ($MILLION)
TABLE 13 U.S. IVD TISSUE DIAGNOSTICS TECHNIQUE MARKET, 2016-2023, ($MILLION)
TABLE 14 U.S. IVD CLINICAL CHEMISTRY TECHNIQUE MARKET, 2016-2023 ($MILLION)
TABLE 15 U.S. OTHER IVD TECHNIQUES MARKET, 2016-2023, ($MILLION)
TABLE 16 U.S. IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 17 U.S. IVD INFECTIOUS DISEASES MARKET, 2016-2023 ($MILLION)
TABLE 18 U.S. IVD CANCER MARKET, 2016-2023 ($MILLION)
TABLE 19 U.S. IVD CARDIAC DISEASES MARKET, 2016-2023 ($MILLION)
TABLE 20 U.S. IVD IMMUNE SYSTEM DISORDER MARKET, 2016-2023 ($MILLION)
TABLE 21 U.S. IVD NEPHROLOGICAL DISEASES MARKET, 2016-2023, ($MILLION)
TABLE 22 U.S. IVD GASTROINTESTINAL DISEASES MARKET, 2016-2023 ($MILLION)
TABLE 23 U.S. IVD OTHER INDICATION MARKET, 2016-2023 ($MILLION)
TABLE 24 U.S. IVD MARKET, BY END USER, 2016-2023, ($MILLION)
TABLE 25 U.S. IVD STANDALONE LABORATORIES MARKET, 2016-2023 ($MILLION)
TABLE 26 U.S. IVD HOSPITALS MARKET, 2016-2023 ($MILLION)
TABLE 27 U.S. IVD ACADEMIC AND MEDICAL SCHOOLS MARKET, 2016-2023 ($MILLION)
TABLE 28 U.S. IVD POINT OF CARE MARKET, 2016-2023 ($MILLION)
TABLE 29 U.S. IVD OTHER END-USER MARKET, 2016-2023 ($MILLION)
TABLE 30 THERMO FISHER SCIENTIFIC INC. COMPANY SNAPSHOT
TABLE 31 ALERE INC. COMPANY SNAPSHOT
TABLE 32 BIOMERIEUX COMPANY SNAPSHOT
TABLE 33 DANAHER CORPORATION COMPANY SNAPSHOT
TABLE 34 ROCHE DIAGNOSTICS COMPANY SNAPSHOT
TABLE 35 BECTON DICKINSON AND COMPANY SNAPSHOT
TABLE 36 BIO-RAD LABORATORIES, INC. COMAPNY SNAPSHOT
TABLE 37 BAYER AG COMPANY SNAPSHOT
TABLE 38 SYSMEX CORPORATION COMPANY SNAPSHOT
TABLE 39 JOHNSON & JOHNSON PVT LTD. COMPANY SNAPSHOT

FIGURE 1 MARKET SEGMENTATION
FIGURE 2 TOP INVESTMENT POCKETS
FIGURE 3 TOP WINNING STRATEGIES, 2014-2016 (%)
FIGURE 4 TOP WINNING STRATEGIES: NATURE AND TYPE, 2014-2016
FIGURE 5 PORTERS FIVE FORCES ANALYSIS
FIGURE 6 MARKET SHARE ANALYSIS: IVD MARKET, 2016
FIGURE 7 U.S. CHEMILUMINESCENCE IMMUNOASSAY (CLISA) MARKET, 2016-2023 ($MILLION)
FIGURE 8 U.S. FLUORESCENCE IMMUNOASSAY (FIA) MARKET, 2016-2023 ($MILLION)
FIGURE 9 U.S. COLORIMETRIC IMMUNOASSAY (CI) MARKET, 2016-2023 ($MILLION)
FIGURE 10 U.S. RAPID TESTS MARKET, 2016-2023 ($MILLION)
FIGURE 11 U.S. ENZYME-LINKED IMMUNOSPOT (ELISPOT) MARKET, 2016-2023 ($MILLION)
FIGURE 12 U.S. RADIOIMMUNOASSAY (RIA) MARKET, 2016-2023 ($MILLION)
FIGURE 13 U.S. WESTERN BLOT TECHNIQUE MARKET, 2016-2023 ($MILLION)
FIGURE 14 U.S. POLYMERIZE CHAIN REACTION PCR MARKET, 2016-2023 ($MILLION)
FIGURE 15 U.S. ISOTHERMAL NUCLEIC ACID TECHNOLOGY (INAAT) MARKET, 2016-2023 ($MILLION)
FIGURE 16 U.S. HYBRIDIZATION MARKET, 2016-2023 ($MILLION)
FIGURE 17 U.S. DNA DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 18 U.S. MICROARRAY MARKET, 2016-2023 ($MILLION)
FIGURE 19 U.S. OTHER MOLECULAR DIAGNOSTIC TECHNIQUE MARKET, 2016-2023 ($MILLION)
FIGURE 20 U.S. BASIC METABOLIC PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 21 U.S. LIVER PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 22 U.S. RENAL PROFILE MARKET, 2016-2023 ($MILLION)
FIGURE 23 U.S. LIPID PROFILE MARKET, 2016-2023 ($MILLION)
FIGURE 24 U.S. THYROID FUNCTION PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 25 U.S. ELECTROLYTE PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 26 U.S. SPECIALITY CHEMICALS MARKET, 2016-2023 ($MILLION)
FIGURE 27 THERMO FISHER SCIENTIFIC INC.: REVENUE, 2014-2016, ($MILLION)
FIGURE 28 THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 29 THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 30 ALERE INC.: REVENUE, 2014-2016, ($MILLION)
FIGURE 31 ALERE INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 32 ALERE INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 33 BIOMERIEUX REVENUE: 2014-2016 ($MILLION)
FIGURE 34 BIOMERIEUX: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 35 BIOMERIEUX: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 36 DANAHER CORPORATION: REVENUE, 2014-2016 ($MILLION)
FIGURE 37 DANAHER CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 38 DANAHER CORPORATION: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 39 ROCHE DIAGNOSTICS: REVENUE, 2014-2016 ($MILLION)
FIGURE 40 ROCHE DIAGNOSTICS: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 41 BECTON, DICKINSON AND COMPANY: REVENUE, 2014-2016 ($MILLION)
FIGURE 42 BECTON DICKINSON AND COMPANY: REVENUES BY SEGMENT (%) (2016)
FIGURE 43 BECTON DICKINSON AND COMPANY: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 44 BIO-RAD LABORATORIES: REVENUE, 2014-2016 ($MILLION)
FIGURE 45 BIO RAD LABORATORIES, INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 46 BIO RAD LABORATORIES, INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 47 BAYER AG: REVENUE, 2014-2016 ($MILLION)
FIGURE 48 BAYER AG: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 49 SYSMEX CORPORATION: REVENUE, 2014-2016 ($MILLION)
FIGURE 50 SYSMEX CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 51 SYSMEX CORPORATION: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 52 JOHNSON & JOHSNON: REVENUE, 2014 - 2016 ($MILLION)
FIGURE 53 JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 54 JOHNSON & JOHNSON: REVENUE SHARE BY GEOGRAPHY, (%)(2016)



★調査レポート[体外診断薬(IVD)の米国市場] (コード:AMR8040232)販売に関する免責事項を必ずご確認ください。
★調査レポート[体外診断薬(IVD)の米国市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆